Sex Differences in Sympathetic Vascular Reactivity at High Altitude
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 17
- 试验地点
- 2
- 主要终点
- Change in systolic, diastolic, and mean arterial blood pressure
研究概览
简要总结
This study aims to investigate sex differences in blood pressure control associated with exposure to acute hypoxia (low oxygen), and short term acclimatization to hypoxia at high altitude.
详细描述
About 200 million people worldwide live at high altitudes and millions of others travel to high altitude every year for work or pleasure. At high altitude participants are exposed to a lower than normal level of oxygen, also known as hypoxia. This causes stress to the human body, which will adapt in order to maintain adequate oxygen delivery to its tissues. One of these adaptations is an increase in activity of participants' sympathetic nervous system ("fight or flight" response). Sympathetic nerve activity affects the size of participants' blood vessels, which in turn will affect blood pressure. Men and women regulate their blood pressure in different ways; for example, women tend to have lower blood pressure and sympathetic nerve activity than men. Women also appear to have less constriction of their blood vessels in response to stress. This may be in part because estrogen causes blood vessels to dilate. It may also be due to differences in the receptors which are activated by the sympathetic nervous system. These receptors are called alpha and beta receptors and respond to sympathetic nerve activity in opposite directions. Women represent 50% of the population living at and travelling to high altitude, therefore, it is important to understand the differences in how men and women respond to low oxygen.
The main purpose of this study is to examine the differences between men and women in the sympathetic nervous system control of blood vessels during exposure to low oxygen. To study this question, the investigators will test how blood vessels respond to stressors in both men and women. Participants will be recruited at the Canadian sites, and the investigators will test them while they breathe low oxygen for a short amount of time at low altitude. The investigators will also perform assessments on the same participants during a two week stay at high altitude at White Mountain, CA, which is at an altitude of 3,800m. These data will have implications in the basic understanding of differences between male and female physiology. Specifically, to males and females living or travelling to high altitude.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
盲法说明
Due to the study design, masking is not possible. The time points and dosages of the study drug will be known to the participant.
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Between ages of 18-50
- •No medical history of cardiovascular, respiratory, nervous system, or metabolic disease
- •Females must be pre-menopausal
排除标准
- •Any known cardiovascular, respiratory, nervous system, or metabolic disease (however, participants with controlled arterial hypertension will not be excluded)
- •Having travelled above 2,000m within 1 month of testing at low and high altitude
- •Females who are pregnant, confirmed by a pregnancy test
- •Females who are post-menopausal
- •Participants that are classified as obese (body mass index > 30kg⋅m²)
- •Participants who are current daily smokers
- •Those with a known allergy to sulfites
- •Participants taking monoamine oxidase (MAO) inhibitors or tricyclic antidepressants or other medications that have contraindications with the study drugs
- •Participants who are still within the washout period from participating in other studies involving drugs.
研究组 & 干预措施
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Rhythmic Handgrip (Other)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Sodium Nitroprusside (Drug)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Phenylephrine Hydrochloride (Drug)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Norepinephrine (Drug)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Isometric Handgrip and Post-Exercise Circulatory Occlusion (Other)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Cold Pressor Test (Other)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Propranolol Hydrochloride (Drug)
Low Altitude
Participants will be assessed at an altitude of <1050m.
干预措施: Phentolamine Mesylate (Drug)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Sodium Nitroprusside (Drug)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Phenylephrine Hydrochloride (Drug)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Norepinephrine (Drug)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Isometric Handgrip and Post-Exercise Circulatory Occlusion (Other)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Rhythmic Handgrip (Other)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Cold Pressor Test (Other)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Propranolol Hydrochloride (Drug)
High Altitude
Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.
干预措施: Phentolamine Mesylate (Drug)
结局指标
主要结局
Change in systolic, diastolic, and mean arterial blood pressure
时间窗: 3 minutes
modified oxford
Propranolol
时间窗: 2 hours
changes in vascular conductance
Change in arterial blood flow
时间窗: 1 hour 30 minutes
phenylephrine and norepinephrine sensitivity
Cold pressor test
时间窗: 3 minutes
sympathetic reactivity
Change in vascular conductance
时间窗: 20 minutes
exercise and metaboreflex reactivity
Phentolamine
时间窗: 1 hour
changes in vascular conductance
次要结局
未报告次要终点
